Twitxy
Saved
@OncLive's profile picture
View on X

OncLive.com

Verified account This account is verified because it's an official organization on X. Learn more

@OncLive

Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
New Jersey, USA onclive.com Joined May 2009
2K Following 51K Followers 121K Posts

Latest posts 5

OncLive.com Verified account @OncLive
Steven Isakoff, MD, PhD, MMSc, of @MassGenBrigham, shares interim data for invikafusp alfa plus sacituzumab govitecan-hziy in metastatic HR+/HER2– or triple-negative breast cancer @sitcancer #SITC26 #bcsm #oncology

Watch now: onclive.com/view/dr-isakof…
www.onclive.com Dr Isakoff on Data for Invikafusp Alfa Plus Sacituzumab Govitecan in Advanced HR+ or Triple-Negat... Steven Isakoff, MD, PhD, MMSc, discusses data for invikafusp alfa plus sacituzumab govitecan in advanced HR-positive or triple-negative breast cancer.
OncLive.com Verified account @OncLive
WATCH: @LauraGrahamMD of @CUAnschutz discusses safety and efficacy data for JNJ-87189401 plus pasritamig in mCRPC @sitcancer #SITC26 #pcsm #oncology

onclive.com/view/dr-graham…
www.onclive.com Dr Graham on Data for JNJ-87189401 Plus Pasritamig in mCRPC | OncLive Laura Graham, MD, discusses phase 1 safety and PSA response data for JNJ-87189401 plus pasritamig in metastatic castration-resistant prostate cancer.
OncLive.com Verified account @OncLive
📰 Preliminary activity was shown for roginolisib in metastatic uveal melanoma according to data from a first-in-human phase 1 study, sending promising signals for patients and researchers

Read more here ➡️: onclive.com/view/roginolis…

#melsm #oncology
www.onclive.com Roginolisib Demonstrates Preliminary Activity in Metastatic Uveal Melanoma | OncLive Phase 1 data support continued investigation of roginolisib in advanced cancers, including metastatic uveal melanoma.